z-logo
Premium
B Cell‐Activating Factor Enhances Interleukin‐6 and Interleukin‐10 Production by ODN‐Activated Human B Cells
Author(s) -
Yehudai D.,
Snir A.,
Peri R.,
Halasz K.,
Haj T.,
Odeh M.,
Kessel A.
Publication year - 2012
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1111/j.1365-3083.2012.02752.x
Subject(s) - b cell activating factor , b cell , interleukin 10 , microbiology and biotechnology , interleukin , chemistry , biology , immunology , immune system , cytokine , antibody
We aim to investigate the additive value of B cell‐activating factor (BAFF) when added to oligodeoxynucleotides (ODN)‐activated B cells with respect to TLR‐9, CD69, MHC‐II expression, IL‐6 and IL‐10 secretion and B cell cycling. Therefore, B cells from healthy individuals were incubated under the following conditions: (1) B cells with medium, (2) B cells with ODN 0.5 μ m , (3) B cells with BAFF 20 μ m and (4) B cells with both ODN 0.5 μ m and BAFF 20 μ m . We found that addition of BAFF did not enhance the expression of TLR‐9, CD69 and MHC‐II in ODN‐activated B cells. Incubation of B cells with BAFF and ODN together leads to a marked elevation of IL‐6 and IL‐10 levels compared to ODN alone. Synthesis and mitosis were higher in B cells stimulated by BAFF than in B cells stimulated by ODN. These findings suggest that both BAFF and TLR‐9 contribute independently to B cell function.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom